Omic for Enterprise
Deploy AI scientists across your organization. Integrate your proprietary data. Access drug discovery capabilities no one else has.
Agentic Life Sciences is Here
Hundreds of agents with deep pharma expertise, integrated with your systems and data.
Omic deploys hundreds of specialized agents across your organization—research, regulatory, clinical, BD, IP, ops. Each understands pharma deeply and integrates with your proprietary systems. Not generic AI. AI that knows your business.
Drug discovery capabilities no one else has
Enterprise partnerships unlock access to computational drug discovery capabilities that don't exist anywhere else.
Digital Patient Models
Uncover disease mechanisms and identify novel targets in digital humans built from systems biology.
We build computational models of patient populations using multi-omics data, clinical records, and mechanistic biology. Digital patients reveal disease mechanisms of action at molecular resolution—uncovering the biological pathways driving pathology.
Run virtual experiments on thousands of digital patients to identify novel therapeutic targets, discover biomarkers, and understand patient stratification before investing in wet lab validation.
Autonomous Drug Discovery
AI agents that design therapeutic candidates, optimize leads, and predict drug properties at computational speed.
Once targets are identified in digital patients, AI screens billions of molecules computationally. Predict binding affinity, selectivity, ADME properties, and toxicity in silico. Design novel chemical matter optimized for your specific target and patient population.
Iterate through hit-to-lead and lead optimization cycles at computational speed. What took months in the wet lab now takes days in silico.
Virtual Clinical Trials
Predict drug efficacy, side effects, and toxicity in digital disease-specific humans. Derisk programs before IND.
Test drug candidates in digital patients built from systems biology data. Predict whether your drug will work in disease-specific patient populations. Model efficacy, side effects, tissue distribution, and toxicity at molecular resolution before clinical trials.
Eliminate candidates with safety liabilities or low efficacy predictions. Optimize dosing, identify responder populations, and derisk your development programs. Generate model-informed drug development (MIDD) packages for regulatory submissions.
Enterprise adds deep integration
Connect Omic to your internal databases, ELNs, and proprietary datasets. Build custom agents and workflows for your specific research questions.
Your data, integrated
Custom MCP servers connect Omic to your internal systems. Your scientists ask questions about proprietary compound libraries, screening results, clinical data, and experimental records. SSO and SAML support. Your data never trains our models.
Custom agents and workflows
Specialized AI agents tailored to your therapeutic areas and research processes. Automated analysis pipelines for your specific assays. Custom tools that understand your organization's unique workflows and terminology.
Dedicated support
Computational biologists and AI researchers embedded with your team. Weekly syncs. Shared Slack channels. Joint research programs with co-authored publications. We collaborate on your hardest problems.
How it works
Deploy Omic across your team
Every scientist gets access. We integrate with your SSO, set up custom MCP servers for your internal tools, and connect your proprietary datasets. Takes days, not months.
We embed with your team
Dedicated computational biologist joins your research programs. They collaborate on experimental design, build custom analyses, and push your discovery efforts forward.
Operate at computational speed
Your organization runs experiments in silico, validates hypotheses computationally, and moves targets through discovery faster than any traditional lab. Months of work becomes days.
Work With Us
Choose the partnership model that fits your needs
Enterprise Partnership
Deploy Omic across your organization. Get AI scientists for every researcher, deep integration with your systems, and dedicated computational biology support.
Asset Licensing
License our proprietary digital patient models, target discovery algorithms, and computational drug design capabilities for specific therapeutic areas.
Bring Omic to your organization
Email us at eureka@omic.ai or schedule time to discuss your research goals.
Schedule a Meeting